These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


235 related items for PubMed ID: 2513379

  • 41. Supplemental zinc (Zn2+) restores antibody formation in cultures of aged spleen cells. II. Effects on mediator production.
    Winchurch RA, Togo J, Adler WH.
    Eur J Immunol; 1987 Jan; 17(1):127-32. PubMed ID: 3493154
    [Abstract] [Full Text] [Related]

  • 42. Depletion of IL-10- and TGF-beta-producing regulatory gamma delta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells.
    Seo N, Tokura Y, Takigawa M, Egawa K.
    J Immunol; 1999 Jul 01; 163(1):242-9. PubMed ID: 10384122
    [Abstract] [Full Text] [Related]

  • 43. Potent enhancement of cellular and humoral immune responses against recombinant hepatitis B antigens using AS02A adjuvant in healthy adults.
    Vandepapelière P, Rehermann B, Koutsoukos M, Moris P, Garçon N, Wettendorff M, Leroux-Roels G.
    Vaccine; 2005 Apr 08; 23(20):2591-601. PubMed ID: 15780441
    [Abstract] [Full Text] [Related]

  • 44. A synthetic analogue of phosphatidylinositol mannoside is an efficient adjuvant.
    Denis M, Ainge GD, Larsen DS, Severn WB, Painter GF.
    Immunopharmacol Immunotoxicol; 2009 Apr 08; 31(4):577-82. PubMed ID: 19874225
    [Abstract] [Full Text] [Related]

  • 45. In vitro effects of melatonin on mitogen-induced lymphocyte proliferation and cytokine expression in young and old rats.
    Pahlavani MA, Harris MD.
    Immunopharmacol Immunotoxicol; 1997 Aug 08; 19(3):327-37. PubMed ID: 9248861
    [Abstract] [Full Text] [Related]

  • 46. Human recombinant IL-6/B cell stimulatory factor 2 augments murine antigen-specific antibody responses in vitro and in vivo.
    Takatsuki F, Okano A, Suzuki C, Chieda R, Takahara Y, Hirano T, Kishimoto T, Hamuro J, Akiyama Y.
    J Immunol; 1988 Nov 01; 141(9):3072-7. PubMed ID: 2459240
    [Abstract] [Full Text] [Related]

  • 47. Involvement of gamma interferon in antibody enhancement by adjuvants.
    Odean MJ, Frane CM, Van derVieren M, Tomai MA, Johnson AG.
    Infect Immun; 1990 Feb 01; 58(2):427-32. PubMed ID: 2105274
    [Abstract] [Full Text] [Related]

  • 48. Effect of an orally applied herbal immunomodulator on cytokine induction and antibody response in normal and immunosuppressed mice.
    Bodinet C, Lindequist U, Teuscher E, Freudenstein J.
    Phytomedicine; 2002 Oct 01; 9(7):606-13. PubMed ID: 12487324
    [Abstract] [Full Text] [Related]

  • 49. Monophosphoryl lipid A (MPL) upregulates major histocompatibility complex (MHC) class I expression by increasing interferon-gamma (IFN-gamma).
    Cho CH, Lee BK, Kwak SM, Kim JD.
    Yonsei Med J; 1999 Feb 01; 40(1):20-5. PubMed ID: 10198602
    [Abstract] [Full Text] [Related]

  • 50. Comparison of liposome-polycation-DNA(LPD) and monophosphoryl lipid A(MPL) adjuvant formulations in BALB/c mice models.
    Zhang XP, Cui WH.
    Immunol Invest; 2012 Feb 01; 41(4):356-66. PubMed ID: 21864115
    [Abstract] [Full Text] [Related]

  • 51. Release of a mitogenic factor by splenic Lyt 1+ T-cells from mice treated with SSM, an immunomodulator extracted from human type tubercle bacilli.
    Pollard RB, Schmitt DA, Sasaki H, Hayashi Y, Suzuki F.
    Anticancer Res; 1990 Feb 01; 10(2A):285-90. PubMed ID: 2346302
    [Abstract] [Full Text] [Related]

  • 52. The role of macrophages in the adjuvant effect on antibody production of Corynebacterium parvum.
    Watson SR, Sljivić VS.
    Clin Exp Immunol; 1976 Jan 01; 23(1):149-53. PubMed ID: 770033
    [Abstract] [Full Text] [Related]

  • 53. Studies of immunomodulating actions of carotenoids. II. Astaxanthin enhances in vitro antibody production to T-dependent antigens without facilitating polyclonal B-cell activation.
    Jyonouchi H, Zhang L, Tomita Y.
    Nutr Cancer; 1993 Jan 01; 19(3):269-80. PubMed ID: 8346076
    [Abstract] [Full Text] [Related]

  • 54. Regulation of isotype immunoglobulin and interleukin production by adjuvants in vitro.
    Karagouni EE, Hadjipetrou-Kourounakis L.
    J Clin Lab Immunol; 1990 Sep 01; 33(1):29-39. PubMed ID: 1726221
    [Abstract] [Full Text] [Related]

  • 55. Differential antibody production of adherent and nonadherent spleen cells transferred to irradiated and cyclophosphamide-treated recipient mice.
    Albright JF, Deitchman JW, Hassell SA, Ozato K.
    J Reticuloendothel Soc; 1975 Apr 01; 17(4):195-209. PubMed ID: 1097674
    [No Abstract] [Full Text] [Related]

  • 56. Complement-induced mixed aggregation of T and B lymphocytes and myeloid cells and the effect of adjuvant.
    Arnaiz-Villena A, Roitt IM.
    Clin Exp Immunol; 1975 Jul 01; 21(1):115-20. PubMed ID: 171110
    [Abstract] [Full Text] [Related]

  • 57. Functional maturation of B cells in vitro.
    Stocker JW.
    Immunology; 1977 Mar 01; 32(3):275-81. PubMed ID: 66196
    [Abstract] [Full Text] [Related]

  • 58. Lipopolysaccharide and monophosphoryl lipid A differentially regulate interleukin-12, gamma interferon, and interleukin-10 mRNA production in murine macrophages.
    Salkowski CA, Detore GR, Vogel SN.
    Infect Immun; 1997 Aug 01; 65(8):3239-47. PubMed ID: 9234781
    [Abstract] [Full Text] [Related]

  • 59. Alterations in frequency of interleukin-2 (IL-2)-, gamma interferon-, or IL-4-secreting splenocytes induced by Candida albicans mannan and/or monophosphoryl lipid A.
    Li SP, Lee SI, Domer JE.
    Infect Immun; 1998 Apr 01; 66(4):1392-9. PubMed ID: 9529058
    [Abstract] [Full Text] [Related]

  • 60. The low-toxicity versions of LPS, MPL adjuvant and RC529, are efficient adjuvants for CD4+ T cells.
    Thompson BS, Chilton PM, Ward JR, Evans JT, Mitchell TC.
    J Leukoc Biol; 2005 Dec 01; 78(6):1273-80. PubMed ID: 16204643
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.